Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

Gemcitabine and nab-paclitaxel (GEM-NAB) and the combination of 5-fluorouracil, oxaliplatin, and irinotecan (FOLFIRINOX) are valid first-line options for advanced or metastatic pancreatic cancer (mPC). However, no randomized trials comparing the two schemes have been performed. This meta-analysis ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Pusceddu, Sara, Ghidini, Michele, Torchio, Martina, Corti, Francesca, Tomasello, Gianluca, Niger, Monica, Prinzi, Natalie, Nichetti, Federico, Coinu, Andrea, Di Bartolomeo, Maria, Cabiddu, Mary, Passalacqua, Rodolfo, de Braud, Filippo, Petrelli, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520876/
https://www.ncbi.nlm.nih.gov/pubmed/30959763
http://dx.doi.org/10.3390/cancers11040484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520876/
https://www.ncbi.nlm.nih.gov/pubmed/30959763
http://dx.doi.org/10.3390/cancers11040484

Ejemplares similares